Better Therapeutics, Inc. (NASDAQ: BTTX) reported Q3 EPS of ($0.24), $0.07 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Better Therapeutics, Inc. (BTTX) click here.